Vaidyo Narayano Hari Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-05-2024
- Paid Up Capital ₹ 0.10 M
as on 25-05-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit -16.67%
(FY 2020)
- Ebitda -50.00%
(FY 2020)
- Net Worth -50.00%
(FY 2020)
- Total Assets %
(FY 2020)
About Vaidyo Narayano Hari Pharmaceuticals
The Corporate was formerly known as Zooz Pharmaceuticals Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Boddu and Mateti Srinivas serve as directors at the Company.
- CIN/LLPIN
U24299TG2017PTC117004
- Company No.
117004
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vaidyo Narayano Hari Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Boddu  | Director | 10-May-2017 | Current |
| Mateti Srinivas | Director | 10-May-2017 | Current |
Financial Performance of Vaidyo Narayano Hari Pharmaceuticals.
Vaidyo Narayano Hari Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 16.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 50%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaidyo Narayano Hari Pharmaceuticals?
Unlock access to Vaidyo Narayano Hari Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vnh-P Pharmaceuticals Private LimitedActive 5 years 4 monthsSantosh Boddu and Mateti Srinivas are mutual person
- Vnh Pharmaceuticals Private LimitedActive 7 years 7 months
Santosh Boddu and Mateti Srinivas are mutual person
- Shloka Institute Of Foreign Languages Private LimitedActive 7 years 1 month
Santosh Boddu is a mutual person
- Creativenest Business Solutions Private LimitedActive 9 months 25 days
Mateti Srinivas is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaidyo Narayano Hari Pharmaceuticals?
Unlock and access historical data on people associated with Vaidyo Narayano Hari Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaidyo Narayano Hari Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaidyo Narayano Hari Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
